Table of contents
Volume 95, Issue 8
Published online 17 October 2006 (953-1129)
Minireviews |
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Book Reviews
Editorial
A perspective on euthanasia FREE
D Oliver
Br J Cancer 95: 953-954; doi:10.1038/sj.bjc.6603365
Minireviews
Predicted mechanisms of resistance to mTOR inhibitors FREE
R T Kurmasheva, S Huang and P J Houghton
Br J Cancer 95: 955-960; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603353
A novel proteasome inhibitor NPI-0052 as an anticancer therapy FREE
D Chauhan, T Hideshima and K C Anderson
Br J Cancer 95: 961-965; doi:10.1038/sj.bjc.6603406
Clinical Studies
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer FREE
C von Plessen, B Bergman, O Andresen, R M Bremnes, S Sundstrøm, M Gilleryd, R Stephens, J Vilsvik, U Aasebø and S Sörenson for the Norwegian Lung Cancer Study Group
Br J Cancer 95: 966-973; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603383
Familial breast cancer: management of 'lower risk' referrals FREE
D Young, L McLeish, F Sullivan, M Pitkethly, M Reis, D Goudie, H Vysny, G Ozakinci and M Steel
Br J Cancer 95: 974-978; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603389
The impact of the Calman–Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients FREE
E Morris, R A Haward, M S Gilthorpe, C Craigs and D Forman
Br J Cancer 95: 979-985; doi:10.1038/sj.bjc.6603372
Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients FREE
J Fernebro, A Bladström, A Rydholm, P Gustafson, H Olsson, J Engellau and M Nilbert
Br J Cancer 95: 986-990; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603401
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas FREE
S Wagner, M Benesch, F Berthold, A K Gnekow, S Rutkowski, R Sträter, M Warmuth-Metz, R-D Kortmann, T Pietsch and J E A Wolff
Br J Cancer 95: 991-997; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603402
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations FREE
H Asahina, K Yamazaki, I Kinoshita, N Sukoh, M Harada, H Yokouchi, T Ishida, S Ogura, T Kojima, Y Okamoto, Y Fujita, H Dosaka–Akita, H Isobe and M Nishimura on behalf of the Hokkaido Lung Cancer Clinical Study Group
Br J Cancer 95: 998-1004; doi:10.1038/sj.bjc.6603393
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study FREE
G Frasci, G D'Aiuto, P Comella, R Thomas, G Botti, M Di Bonito, V De Rosa, G Iodice, M R Rubulotta and G Comella for the Southern Italy Cooperative Oncology Group (SICOG)- Italy
Br J Cancer 95: 1005-1012; doi:10.1038/sj.bjc.6603395
Translational Therapeutics
Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-
and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation FREE
G Vlahovic, Z N Rabbani, J E Herndon II, M W Dewhirst and Z Vujaskovic
Br J Cancer 95: 1013-1019; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603366
The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro FREE
T Alain, M Kim, R N Johnston, S Urbanski, A E Kossakowska, P A Forsyth and P W K Lee
Br J Cancer 95: 1020-1027; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603363
Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice FREE
C Bing, S Russell, E Becket, M Pope, M J Tisdale, P Trayhurn and J R Jenkins
Br J Cancer 95: 1028-1037; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603360
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells FREE
I Fabian, D Reuveni, A Levitov, D Halperin, E Priel and I Shalit
Br J Cancer 95: 1038-1046; doi:10.1038/sj.bjc.6603355
Molecular Diagnostics
Case–control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele FREE
E L Webb, M F Rudd and R S Houlston
Br J Cancer 95: 1047-1049; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603382
Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma FREE
K T Ng, K Man, C K Sun, T K Lee, R T Poon, C-M Lo and S-T Fan
Br J Cancer 95: 1050-1055; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603399
Altered sirtuin expression is associated with node-positive breast cancer FREE
N Ashraf, S Zino, A MacIntyre, D Kingsmore, A P Payne, W D George and P G Shiels
Br J Cancer 95: 1056-1061; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603384
Prognostic value of increase in transcript levels of Tp73 
Ex2-3 isoforms in low-grade glioma patients FREE
M Wager, J Guilhot, J-L Blanc, S Ferrand, S Milin, B Bataille, F Lapierre, S Denis, T Chantereau, C-J Larsen and L Karayan-Tapon
Br J Cancer 95: 1062-1069; doi:10.1038/sj.bjc.6603410
Novel heteroduplex method using small cytology specimens with a remarkably high success rate for analysing EGFR gene mutations with a significant correlation to gefitinib efficacy in non-small-cell lung cancer FREE
F Oshita, S Matsukuma, M Yoshihara, Y Sakuma, N Ohgane, Y Kameda, H Saito, K Yamada, E Tsuchiya and Y Miyagi
Br J Cancer 95: 1070-1075; doi:10.1038/sj.bjc.6603396
The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer FREE
S Ramsey, G W A Lamb, M Aitchison and D C McMillan
Br J Cancer 95: 1076-1080; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603387
Prognostic relevance of Tiam1 protein expression in prostate carcinomas FREE
R Engers, M Mueller, A Walter, J G Collard, R Willers and H E Gabbert
Br J Cancer 95: 1081-1086; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603385
Genetics and Genomics
Association of decreased mitochondrial DNA content with ovarian cancer progression FREE
Y Wang, V W S Liu, W C Xue, A N Y Cheung and H Y S Ngan
Br J Cancer 95: 1087-1091; advance online publication, October 3, 2006; doi:10.1038/sj.bjc.6603377
Gene expression profiling of human ovarian tumours FREE
S Biade, M Marinucci, J Schick, D Roberts, G Workman, E H Sage, P J O'Dwyer, V A LiVolsi and S W Johnson
Br J Cancer 95: 1092-1100; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603346
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer FREE
E Miranda, A Destro, A Malesci, E Balladore, P Bianchi, E Baryshnikova, G Franchi, E Morenghi, L Laghi, L Gennari and M Roncalli
Br J Cancer 95: 1101-1107; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603337
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia FREE
A Scardocci, F Guidi, F D'Alo', D Gumiero, E Fabiani, A DiRuscio, M Martini, L M Larocca, M Zollino, S Hohaus, G Leone and M T Voso
Br J Cancer 95: 1108-1113; doi:10.1038/sj.bjc.6603392
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis FREE
M L Davidsen, SØ Würtz, M U Rømer, N M Sørensen, S K Johansen, I J Christensen, J K Larsen, H Offenberg, N Brünner and U Lademann
Br J Cancer 95: 1114-1120; doi:10.1038/sj.bjc.6603378
Letters to the Editor
Enhancing the quality of clinical trials in cancer pain first requires that pain assessment methods are appropriately understood and used FREE
A Caraceni, C Brunelli, C Martini, E Zecca and F De Conno
Br J Cancer 95: 1121; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603357
A model of the natural history of screen-detected prostate cancer FREE
C Metcalfe, J A Lane, F Hamdy, D Neal and J L Donovan on behalf of the ProtecT Study Research Group
Br J Cancer 95: 1122-1123; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603368
Familial ovarian screening – effective or ineffective? FREE
I J Jacobs, J Mackay, U Menon, S J Skates, A N Rosenthal and L Fraser
Br J Cancer 95: 1124; doi:10.1038/sj.bjc.6603407
High percentage of abnormal findings on TVU needs further discussion FREE
M J E Mourits, N M van der Velde, H J G Arts and G H de Bock
Br J Cancer 95: 1125; doi:10.1038/sj.bjc.6603408
Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening? FREE
A L M Oei, L F A G Massuger, J Bulten, M J L Ligtenberg, N Hoogerbrugge and J A de Hullu
Br J Cancer 95: 1126-1127; doi:10.1038/sj.bjc.6603409
Book Reviews
The Molecular Biology of Cancer FREE
V Emuss
Br J Cancer 95: 1128; doi:10.1038/sj.bjc.6603379
Death and Medical Power: An Ethical Analysis of Dutch Euthanasia Practice FREE
D Oliver
Br J Cancer 95: 1129; doi:10.1038/sj.bjc.6603373
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
